论文信息 - AZD-9056, a P2X7 receptor inhibitor, suppresses ATP-induced melanogenesis. - 字舞流文

AZD-9056, a P2X7 receptor inhibitor, suppresses ATP-induced melanogenesis.

Ji Young Kim | Jinu Lee | S. Oh | E. J. Lee | Y. Ahn | Sujin Park | Yun Jeong Seong

[1] Ji Young Kim,et al. ATP-P2X7-induced inflammasome activation contributes to melanocyte death and CD8+ T-cell trafficking to the skin in vitiligo. , 2020, The Journal of investigative dermatology.

[2] Z. Abdel‐Malek. Fueling Melanocytes with ATP from Keratinocytes Accelerates Melanin Synthesis. , 2019, The Journal of investigative dermatology.

[3] Ji Young Kim,et al. Critical Role of ATP-P2X7 Axis in UV-Induced Melanogenesis. , 2019, The Journal of investigative dermatology.

[4] R. Coutinho-Silva,et al. The P2X7 Receptor in Inflammatory Diseases: Angel or Demon? , 2018, Front. Pharmacol..

[5] Geoffrey Burnstock,et al. The therapeutic potential of purinergic signalling. , 2010, Biochemical pharmacology.

[6] G. Burnstock,et al. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression , 2017, Purinergic Signalling.

[7] T. Kawate,et al. Structural basis for subtype-specific inhibition of the P2X7 receptor , 2016, eLife.

[8] P. Fiorina,et al. The dark side of extracellular ATP in kidney diseases. , 2015, Journal of the American Society of Nephrology : JASN.

[9] D. Fisher,et al. Melanocyte biology and skin pigmentation , 2007, Nature.

[10] Francisco Solano,et al. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. , 2006, Pigment cell research.